Determining the ER status of a breast tumor is crucial because it influences the treatment approach. ER-positive cancers are often treated with hormone therapies that block estrogen's effects. These therapies can include selective estrogen receptor modulators (SERMs) like tamoxifen, aromatase inhibitors, and selective estrogen receptor degraders (SERDs) such as fulvestrant.
